🇺🇸 FDA
Pipeline program

Urinary kallidinogenase for injection

TK-LAA

Unknown small_molecule active

Quick answer

Urinary kallidinogenase for injection for Acute Ischemic Stroke is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Acute Ischemic Stroke
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials